Evidence map›Paper›PMID 36678364›Full record

ArticlePathogens (Basel, Switzerland)2022

Validating Immunomodulatory Responses of r-

Rajkishor Pandey, Rohit Kumar Gautam, Simran Sharma, Mebrahtu G Tedla, Vijay Mahantesh, Manas Ranjan Dikhit, Akhilesh Kumar, Krishna Pandey, Sanjiva Bimal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Rajkishor PandeyDepartment of Biotechnology, National Institute of Pharmaceutical Education & Research, Hajipur 844102, India.ORCID 0000-0002-2693-2928
Rohit Kumar GautamDepartment of Biotechnology, National Institute of Pharmaceutical Education & Research, Hajipur 844102, India.ORCID 0000-0001-7525-8290
Simran SharmaDepartment of Basic and Applied Sciences, National Institute of Food Technology Entrepreneurship & Management (NIFTEM), Kundli, Sonipat 131028, India.ORCID 0000-0003-3477-2335
Mebrahtu G TedlaDepartment of Child Health, School of Medicine, University of Missouri-Columbia, Columbia, MO 65211, USA.ORCID 0000-0002-0903-3269
Vijay MahanteshDepartment of Biotechnology, National Institute of Pharmaceutical Education & Research, Hajipur 844102, India.
Manas Ranjan DikhitDepartment of Biomedical Informatics, Rajendra Memorial Research Institute of Medical Sciences, Patna 800007, India.
Akhilesh KumarDivision of Immunology, Rajendra Memorial Research Institute of Medical Sciences, Patna 800007, India.ORCID 0000-0001-8782-7390
Krishna PandeyDepartment of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences, Patna 800007, India.
Sanjiva BimalDivision of Immunology, Rajendra Memorial Research Institute of Medical Sciences, Patna 800007, India.
Rajendra Memorial Research Institute of Medical Sciences · INNational Institute of Food Technology Entrepreneurship and Management · INUniversity of Missouri Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination is considered the most appropriate way to control visceral leishmaniasis (VL). With this background, the r-

Indexed as

Leishmania donovaniMHC Class-IIODCreverse vaccinologyT cellvisceral leishmaniasis

Identifiers

PMID36678364
PMCPMC9867430
OpenAlexW4312173453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.